nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Prazosin—HTR1A—stomach cancer	0.00331	1	CrCbGaD
Alfuzosin—Malaise—Capecitabine—stomach cancer	0.00119	0.00156	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—stomach cancer	0.00119	0.00156	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—stomach cancer	0.00119	0.00156	CcSEcCtD
Alfuzosin—Vertigo—Capecitabine—stomach cancer	0.00119	0.00155	CcSEcCtD
Alfuzosin—Syncope—Capecitabine—stomach cancer	0.00118	0.00155	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—stomach cancer	0.00118	0.00154	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—stomach cancer	0.00118	0.00154	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—stomach cancer	0.00118	0.00154	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—stomach cancer	0.00118	0.00154	CcSEcCtD
Alfuzosin—Palpitations—Capecitabine—stomach cancer	0.00117	0.00153	CcSEcCtD
Alfuzosin—Chest pain—Docetaxel—stomach cancer	0.00116	0.00152	CcSEcCtD
Alfuzosin—Arthralgia—Docetaxel—stomach cancer	0.00116	0.00152	CcSEcCtD
Alfuzosin—Loss of consciousness—Capecitabine—stomach cancer	0.00116	0.00152	CcSEcCtD
Alfuzosin—Asthenia—Irinotecan—stomach cancer	0.00116	0.00151	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—stomach cancer	0.00115	0.00151	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00115	0.00151	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—stomach cancer	0.00115	0.0015	CcSEcCtD
Alfuzosin—Dry mouth—Docetaxel—stomach cancer	0.00114	0.00149	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.00114	0.00149	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—stomach cancer	0.00113	0.00148	CcSEcCtD
Alfuzosin—Arthralgia—Capecitabine—stomach cancer	0.00112	0.00147	CcSEcCtD
Alfuzosin—Chest pain—Capecitabine—stomach cancer	0.00112	0.00147	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—stomach cancer	0.00112	0.00147	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00112	0.00146	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—stomach cancer	0.00112	0.00146	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—stomach cancer	0.00111	0.00146	CcSEcCtD
Alfuzosin—Oedema—Docetaxel—stomach cancer	0.00111	0.00146	CcSEcCtD
Alfuzosin—Discomfort—Capecitabine—stomach cancer	0.00111	0.00145	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—stomach cancer	0.00111	0.00145	CcSEcCtD
Alfuzosin—Infection—Docetaxel—stomach cancer	0.00111	0.00145	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—stomach cancer	0.00111	0.00145	CcSEcCtD
Alfuzosin—Diarrhoea—Irinotecan—stomach cancer	0.0011	0.00144	CcSEcCtD
Alfuzosin—Dry mouth—Capecitabine—stomach cancer	0.0011	0.00144	CcSEcCtD
Alfuzosin—Shock—Docetaxel—stomach cancer	0.0011	0.00143	CcSEcCtD
Alfuzosin—Nervous system disorder—Docetaxel—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Pruritus—Fluorouracil—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Thrombocytopenia—Docetaxel—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—stomach cancer	0.00109	0.00143	CcSEcCtD
Alfuzosin—Tachycardia—Docetaxel—stomach cancer	0.00109	0.00142	CcSEcCtD
Alfuzosin—Skin disorder—Docetaxel—stomach cancer	0.00108	0.00141	CcSEcCtD
Alfuzosin—Oedema—Capecitabine—stomach cancer	0.00108	0.00141	CcSEcCtD
Alfuzosin—Infection—Capecitabine—stomach cancer	0.00107	0.0014	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00107	0.0014	CcSEcCtD
Alfuzosin—Dizziness—Irinotecan—stomach cancer	0.00107	0.00139	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—stomach cancer	0.00106	0.00139	CcSEcCtD
Alfuzosin—Shock—Capecitabine—stomach cancer	0.00106	0.00139	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—stomach cancer	0.00106	0.00139	CcSEcCtD
Alfuzosin—Nervous system disorder—Capecitabine—stomach cancer	0.00106	0.00138	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—stomach cancer	0.00106	0.00138	CcSEcCtD
Alfuzosin—Diarrhoea—Fluorouracil—stomach cancer	0.00106	0.00138	CcSEcCtD
Alfuzosin—Thrombocytopenia—Capecitabine—stomach cancer	0.00106	0.00138	CcSEcCtD
Alfuzosin—Tachycardia—Capecitabine—stomach cancer	0.00105	0.00138	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—stomach cancer	0.00105	0.00137	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—stomach cancer	0.00105	0.00137	CcSEcCtD
Alfuzosin—Skin disorder—Capecitabine—stomach cancer	0.00105	0.00137	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—stomach cancer	0.00104	0.00137	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—stomach cancer	0.00104	0.00137	CcSEcCtD
Alfuzosin—Hyperhidrosis—Capecitabine—stomach cancer	0.00104	0.00136	CcSEcCtD
Alfuzosin—Hypotension—Docetaxel—stomach cancer	0.00104	0.00136	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—stomach cancer	0.00104	0.00136	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—stomach cancer	0.00104	0.00136	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00103	0.00135	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—stomach cancer	0.00103	0.00134	CcSEcCtD
Alfuzosin—Vomiting—Irinotecan—stomach cancer	0.00102	0.00134	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—stomach cancer	0.00102	0.00134	CcSEcCtD
Alfuzosin—Dizziness—Fluorouracil—stomach cancer	0.00102	0.00133	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—stomach cancer	0.00102	0.00133	CcSEcCtD
Alfuzosin—Rash—Irinotecan—stomach cancer	0.00102	0.00133	CcSEcCtD
Alfuzosin—Dermatitis—Irinotecan—stomach cancer	0.00102	0.00133	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00101	0.00133	CcSEcCtD
Alfuzosin—Headache—Irinotecan—stomach cancer	0.00101	0.00132	CcSEcCtD
Alfuzosin—Hypotension—Capecitabine—stomach cancer	0.00101	0.00132	CcSEcCtD
Alfuzosin—Somnolence—Docetaxel—stomach cancer	0.00099	0.00129	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—stomach cancer	0.00099	0.00129	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—stomach cancer	0.000988	0.00129	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000983	0.00128	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—stomach cancer	0.000981	0.00128	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—stomach cancer	0.000981	0.00128	CcSEcCtD
Alfuzosin—Vomiting—Fluorouracil—stomach cancer	0.000981	0.00128	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—stomach cancer	0.000981	0.00128	CcSEcCtD
Alfuzosin—Dyspepsia—Docetaxel—stomach cancer	0.00098	0.00128	CcSEcCtD
Alfuzosin—Rash—Fluorouracil—stomach cancer	0.000973	0.00127	CcSEcCtD
Alfuzosin—Dermatitis—Fluorouracil—stomach cancer	0.000972	0.00127	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—stomach cancer	0.000971	0.00127	CcSEcCtD
Alfuzosin—Headache—Fluorouracil—stomach cancer	0.000967	0.00126	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000966	0.00126	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000962	0.00126	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—stomach cancer	0.000962	0.00126	CcSEcCtD
Alfuzosin—Fatigue—Docetaxel—stomach cancer	0.00096	0.00126	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—stomach cancer	0.000959	0.00125	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—stomach cancer	0.000959	0.00125	CcSEcCtD
Alfuzosin—Nausea—Irinotecan—stomach cancer	0.000957	0.00125	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—stomach cancer	0.000953	0.00125	CcSEcCtD
Alfuzosin—Constipation—Docetaxel—stomach cancer	0.000953	0.00125	CcSEcCtD
Alfuzosin—Pain—Docetaxel—stomach cancer	0.000953	0.00125	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—stomach cancer	0.000951	0.00124	CcSEcCtD
Alfuzosin—Dyspepsia—Capecitabine—stomach cancer	0.000949	0.00124	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000931	0.00122	CcSEcCtD
Alfuzosin—Fatigue—Capecitabine—stomach cancer	0.00093	0.00122	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—stomach cancer	0.000926	0.00121	CcSEcCtD
Alfuzosin—Constipation—Capecitabine—stomach cancer	0.000922	0.00121	CcSEcCtD
Alfuzosin—Pain—Capecitabine—stomach cancer	0.000922	0.00121	CcSEcCtD
Alfuzosin—Feeling abnormal—Docetaxel—stomach cancer	0.000918	0.0012	CcSEcCtD
Alfuzosin—Nausea—Fluorouracil—stomach cancer	0.000917	0.0012	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—stomach cancer	0.000914	0.0012	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—stomach cancer	0.000913	0.00119	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000911	0.00119	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—stomach cancer	0.000908	0.00119	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—stomach cancer	0.000908	0.00119	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—stomach cancer	0.00089	0.00116	CcSEcCtD
Alfuzosin—Feeling abnormal—Capecitabine—stomach cancer	0.000889	0.00116	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—stomach cancer	0.000888	0.00116	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—stomach cancer	0.000887	0.00116	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—stomach cancer	0.000884	0.00116	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000882	0.00115	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000882	0.00115	CcSEcCtD
Alfuzosin—Abdominal pain—Docetaxel—stomach cancer	0.000881	0.00115	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—stomach cancer	0.000857	0.00112	CcSEcCtD
Alfuzosin—Urticaria—Capecitabine—stomach cancer	0.000857	0.00112	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—stomach cancer	0.000854	0.00112	CcSEcCtD
Alfuzosin—Abdominal pain—Capecitabine—stomach cancer	0.000853	0.00111	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—stomach cancer	0.000837	0.0011	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—stomach cancer	0.000837	0.0011	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000832	0.00109	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—stomach cancer	0.00083	0.00109	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—stomach cancer	0.000827	0.00108	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—stomach cancer	0.000827	0.00108	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—stomach cancer	0.000826	0.00108	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—stomach cancer	0.000824	0.00108	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—stomach cancer	0.000813	0.00106	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—stomach cancer	0.000809	0.00106	CcSEcCtD
Alfuzosin—Asthenia—Docetaxel—stomach cancer	0.000799	0.00104	CcSEcCtD
Alfuzosin—Infection—Methotrexate—stomach cancer	0.000798	0.00104	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—stomach cancer	0.00079	0.00103	CcSEcCtD
Alfuzosin—Pruritus—Docetaxel—stomach cancer	0.000788	0.00103	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—stomach cancer	0.000787	0.00103	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—stomach cancer	0.000786	0.00103	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—stomach cancer	0.000784	0.00102	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—stomach cancer	0.000784	0.00102	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—stomach cancer	0.00078	0.00102	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000778	0.00102	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—stomach cancer	0.000776	0.00101	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—stomach cancer	0.000774	0.00101	CcSEcCtD
Alfuzosin—Asthenia—Capecitabine—stomach cancer	0.000774	0.00101	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—stomach cancer	0.000768	0.001	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—stomach cancer	0.000766	0.001	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—stomach cancer	0.000765	0.001	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—stomach cancer	0.000764	0.000999	CcSEcCtD
Alfuzosin—Pruritus—Capecitabine—stomach cancer	0.000763	0.000998	CcSEcCtD
Alfuzosin—Diarrhoea—Docetaxel—stomach cancer	0.000762	0.000997	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—stomach cancer	0.000753	0.000984	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—stomach cancer	0.000751	0.000982	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—stomach cancer	0.00075	0.000981	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—stomach cancer	0.000749	0.000979	CcSEcCtD
Alfuzosin—Infection—Epirubicin—stomach cancer	0.000746	0.000976	CcSEcCtD
Alfuzosin—Shock—Epirubicin—stomach cancer	0.000739	0.000967	CcSEcCtD
Alfuzosin—Diarrhoea—Capecitabine—stomach cancer	0.000738	0.000965	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—stomach cancer	0.000737	0.000963	CcSEcCtD
Alfuzosin—Dizziness—Docetaxel—stomach cancer	0.000737	0.000963	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—stomach cancer	0.000736	0.000962	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—stomach cancer	0.000733	0.000959	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000731	0.000956	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—stomach cancer	0.00073	0.000954	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—stomach cancer	0.000726	0.00095	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—stomach cancer	0.000725	0.000948	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—stomach cancer	0.000725	0.000948	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00072	0.000942	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—stomach cancer	0.000716	0.000937	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—stomach cancer	0.000714	0.000933	CcSEcCtD
Alfuzosin—Dizziness—Capecitabine—stomach cancer	0.000713	0.000933	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—stomach cancer	0.000709	0.000927	CcSEcCtD
Alfuzosin—Vomiting—Docetaxel—stomach cancer	0.000708	0.000926	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—stomach cancer	0.000707	0.000924	CcSEcCtD
Alfuzosin—Rash—Docetaxel—stomach cancer	0.000702	0.000918	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—stomach cancer	0.000702	0.000918	CcSEcCtD
Alfuzosin—Dermatitis—Docetaxel—stomach cancer	0.000702	0.000917	CcSEcCtD
Alfuzosin—Headache—Docetaxel—stomach cancer	0.000698	0.000912	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—stomach cancer	0.000695	0.000909	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000693	0.000906	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—stomach cancer	0.000692	0.000905	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—stomach cancer	0.000691	0.000903	CcSEcCtD
Alfuzosin—Pain—Methotrexate—stomach cancer	0.000687	0.000898	CcSEcCtD
Alfuzosin—Vomiting—Capecitabine—stomach cancer	0.000686	0.000897	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000684	0.000895	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—stomach cancer	0.000684	0.000894	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—stomach cancer	0.000682	0.000891	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000681	0.00089	CcSEcCtD
Alfuzosin—Rash—Capecitabine—stomach cancer	0.00068	0.000889	CcSEcCtD
Alfuzosin—Dermatitis—Capecitabine—stomach cancer	0.000679	0.000888	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—stomach cancer	0.000678	0.000887	CcSEcCtD
Alfuzosin—Headache—Capecitabine—stomach cancer	0.000676	0.000883	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—stomach cancer	0.000675	0.000883	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000672	0.000879	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—stomach cancer	0.000668	0.000873	CcSEcCtD
Alfuzosin—Nausea—Docetaxel—stomach cancer	0.000662	0.000865	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—stomach cancer	0.000662	0.000865	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—stomach cancer	0.000661	0.000865	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000656	0.000858	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—stomach cancer	0.00065	0.000849	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000649	0.000848	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—stomach cancer	0.000648	0.000847	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—stomach cancer	0.000642	0.00084	CcSEcCtD
Alfuzosin—Pain—Epirubicin—stomach cancer	0.000642	0.00084	CcSEcCtD
Alfuzosin—Nausea—Capecitabine—stomach cancer	0.000641	0.000838	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—stomach cancer	0.000638	0.000834	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—stomach cancer	0.000635	0.00083	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000633	0.000828	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—stomach cancer	0.000619	0.00081	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—stomach cancer	0.000618	0.000808	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000614	0.000803	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—stomach cancer	0.000612	0.0008	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.0006	0.000785	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—stomach cancer	0.000599	0.000784	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—stomach cancer	0.000597	0.00078	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—stomach cancer	0.000594	0.000777	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—stomach cancer	0.000594	0.000777	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—stomach cancer	0.000594	0.000777	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—stomach cancer	0.000576	0.000753	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—stomach cancer	0.000573	0.000749	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000568	0.000743	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—stomach cancer	0.000568	0.000743	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—stomach cancer	0.000552	0.000722	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—stomach cancer	0.00055	0.000719	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—stomach cancer	0.000549	0.000718	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—stomach cancer	0.000539	0.000705	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—stomach cancer	0.000532	0.000695	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—stomach cancer	0.000531	0.000694	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—stomach cancer	0.000514	0.000672	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—stomach cancer	0.00051	0.000667	CcSEcCtD
Alfuzosin—Rash—Methotrexate—stomach cancer	0.000506	0.000662	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—stomach cancer	0.000506	0.000661	CcSEcCtD
Alfuzosin—Headache—Methotrexate—stomach cancer	0.000503	0.000658	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—stomach cancer	0.000499	0.000652	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—stomach cancer	0.000497	0.00065	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—stomach cancer	0.000492	0.000643	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—stomach cancer	0.000478	0.000625	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—stomach cancer	0.000477	0.000624	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—stomach cancer	0.000476	0.000622	CcSEcCtD
Alfuzosin—Rash—Epirubicin—stomach cancer	0.000474	0.000619	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—stomach cancer	0.000473	0.000619	CcSEcCtD
Alfuzosin—Headache—Epirubicin—stomach cancer	0.000471	0.000615	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—stomach cancer	0.00046	0.000601	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—stomach cancer	0.000446	0.000584	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—stomach cancer	0.000442	0.000578	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—stomach cancer	0.000438	0.000573	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—stomach cancer	0.000438	0.000573	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—stomach cancer	0.000435	0.000569	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—stomach cancer	0.000413	0.00054	CcSEcCtD
Alfuzosin—ADRA1A—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000112	0.000485	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000109	0.000472	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGG—stomach cancer	0.000108	0.000467	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—ADRB2—stomach cancer	0.000107	0.000461	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FST—stomach cancer	0.000105	0.000454	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PPP2R1A—stomach cancer	0.000105	0.000452	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000105	0.000452	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—IDH3B—stomach cancer	0.000105	0.000451	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SUCLG1—stomach cancer	0.000105	0.000451	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—ADRB2—stomach cancer	0.000105	0.000451	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HSPB1—stomach cancer	0.000104	0.00045	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGTR2—stomach cancer	0.000104	0.00045	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKAA1—stomach cancer	0.000104	0.00045	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2R—stomach cancer	0.000103	0.000445	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BMP2—stomach cancer	0.000103	0.000445	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HBEGF—stomach cancer	0.000103	0.000444	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RGS2—stomach cancer	0.000102	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKR1C3—stomach cancer	0.000102	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GAST—stomach cancer	0.000102	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RBP4—stomach cancer	0.000101	0.000434	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CXCL8—stomach cancer	0.000101	0.000434	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000101	0.000434	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR1A—stomach cancer	0.0001	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.0001	0.000432	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NDUFV1—stomach cancer	9.73e-05	0.000419	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NDUFS1—stomach cancer	9.73e-05	0.000419	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PRKCB—stomach cancer	9.73e-05	0.000419	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ANXA1—stomach cancer	9.7e-05	0.000418	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGG—stomach cancer	9.62e-05	0.000415	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—ADRB2—stomach cancer	9.5e-05	0.00041	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADRB1—stomach cancer	9.39e-05	0.000405	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PPP2R1A—stomach cancer	9.31e-05	0.000401	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	9.31e-05	0.000401	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKAA1—stomach cancer	9.26e-05	0.000399	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RPS6—stomach cancer	8.98e-05	0.000387	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RBP4—stomach cancer	8.95e-05	0.000386	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCL8—stomach cancer	8.94e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	8.91e-05	0.000384	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PRKCB—stomach cancer	8.83e-05	0.000381	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6ST—stomach cancer	8.8e-05	0.000379	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BLVRB—stomach cancer	8.67e-05	0.000374	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PGLS—stomach cancer	8.67e-05	0.000374	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGTR2—stomach cancer	8.66e-05	0.000373	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HSPB1—stomach cancer	8.66e-05	0.000373	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2R—stomach cancer	8.56e-05	0.000369	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BMP2—stomach cancer	8.56e-05	0.000369	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKR1C3—stomach cancer	8.42e-05	0.000363	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR1A—stomach cancer	8.34e-05	0.000359	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPAP2A—stomach cancer	8.27e-05	0.000357	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HBEGF—stomach cancer	8.25e-05	0.000356	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PRKCB—stomach cancer	8.07e-05	0.000348	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ANXA1—stomach cancer	8.05e-05	0.000347	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6R—stomach cancer	7.85e-05	0.000338	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—RHOA—stomach cancer	7.81e-05	0.000337	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADRB1—stomach cancer	7.8e-05	0.000336	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	7.69e-05	0.000332	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	7.69e-05	0.000332	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADRB2—stomach cancer	7.61e-05	0.000328	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BMP2—stomach cancer	7.61e-05	0.000328	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2R—stomach cancer	7.61e-05	0.000328	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	7.48e-05	0.000323	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PPP2R1A—stomach cancer	7.46e-05	0.000322	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RPS6—stomach cancer	7.45e-05	0.000321	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	7.4e-05	0.000319	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NDUFA2—stomach cancer	7.37e-05	0.000318	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FBP1—stomach cancer	7.37e-05	0.000318	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CKB—stomach cancer	7.37e-05	0.000318	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA1—stomach cancer	7.37e-05	0.000318	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PRKCB—stomach cancer	7.33e-05	0.000316	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6ST—stomach cancer	7.3e-05	0.000315	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	7.17e-05	0.000309	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	7.15e-05	0.000308	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—RHOA—stomach cancer	7.09e-05	0.000306	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLIN2—stomach cancer	6.93e-05	0.000299	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	6.93e-05	0.000299	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SMAD4—stomach cancer	6.93e-05	0.000299	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCL8—stomach cancer	6.85e-05	0.000295	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HBEGF—stomach cancer	6.85e-05	0.000295	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CA2—stomach cancer	6.74e-05	0.000291	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RPS6—stomach cancer	6.62e-05	0.000285	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FYN—stomach cancer	6.58e-05	0.000284	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NT5E—stomach cancer	6.57e-05	0.000283	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PGAM1—stomach cancer	6.57e-05	0.000283	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6R—stomach cancer	6.51e-05	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	6.51e-05	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	6.48e-05	0.00028	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—RHOA—stomach cancer	6.48e-05	0.000279	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADRB2—stomach cancer	6.32e-05	0.000272	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PLCE1—stomach cancer	6.27e-05	0.00027	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	6.27e-05	0.00027	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—stomach cancer	6.22e-05	0.000268	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PPP2R1A—stomach cancer	6.19e-05	0.000267	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGFR2—stomach cancer	6.17e-05	0.000266	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	6.08e-05	0.000262	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—UMPS—stomach cancer	6.01e-05	0.000259	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—RHOA—stomach cancer	5.88e-05	0.000254	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	5.79e-05	0.000249	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	5.76e-05	0.000248	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SMAD4—stomach cancer	5.75e-05	0.000248	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—stomach cancer	5.69e-05	0.000245	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IRS2—stomach cancer	5.65e-05	0.000244	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	5.61e-05	0.000242	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PDHA1—stomach cancer	5.59e-05	0.000241	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ECHS1—stomach cancer	5.59e-05	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	5.5e-05	0.000237	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—stomach cancer	5.48e-05	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—stomach cancer	5.47e-05	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FYN—stomach cancer	5.46e-05	0.000235	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FADS1—stomach cancer	5.25e-05	0.000227	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TYMP—stomach cancer	5.25e-05	0.000227	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	5.23e-05	0.000225	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCB—stomach cancer	5.22e-05	0.000225	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6ST—stomach cancer	5.2e-05	0.000224	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—stomach cancer	5.17e-05	0.000223	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGFR2—stomach cancer	5.12e-05	0.000221	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	5.11e-05	0.00022	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	5.05e-05	0.000218	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APC—stomach cancer	4.99e-05	0.000215	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SREBF2—stomach cancer	4.92e-05	0.000212	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—RORA—stomach cancer	4.86e-05	0.00021	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FYN—stomach cancer	4.85e-05	0.000209	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MAPK3—stomach cancer	4.78e-05	0.000206	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IRS2—stomach cancer	4.69e-05	0.000202	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6R—stomach cancer	4.64e-05	0.0002	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	4.59e-05	0.000198	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALDOB—stomach cancer	4.56e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	4.55e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	4.55e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—stomach cancer	4.55e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	4.55e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—stomach cancer	4.54e-05	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	4.35e-05	0.000187	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	4.34e-05	0.000187	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	4.33e-05	0.000187	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	4.31e-05	0.000186	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	4.3e-05	0.000185	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALOX5—stomach cancer	4.23e-05	0.000183	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RHOA—stomach cancer	4.19e-05	0.000181	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IRS2—stomach cancer	4.17e-05	0.00018	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DPYD—stomach cancer	4.17e-05	0.00018	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—stomach cancer	4.14e-05	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APC—stomach cancer	4.14e-05	0.000179	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—stomach cancer	4.04e-05	0.000174	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—stomach cancer	4.03e-05	0.000174	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	3.97e-05	0.000171	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	3.95e-05	0.00017	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	3.88e-05	0.000167	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6R—stomach cancer	3.85e-05	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	3.85e-05	0.000166	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	3.83e-05	0.000165	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	3.78e-05	0.000163	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	3.78e-05	0.000163	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTT1—stomach cancer	3.68e-05	0.000159	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APC—stomach cancer	3.68e-05	0.000159	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	3.68e-05	0.000159	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	3.65e-05	0.000157	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.64e-05	0.000157	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	3.61e-05	0.000156	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	3.6e-05	0.000155	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	3.59e-05	0.000155	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	3.57e-05	0.000154	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.54e-05	0.000153	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	3.53e-05	0.000152	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—stomach cancer	3.5e-05	0.000151	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RHOA—stomach cancer	3.48e-05	0.00015	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ENO1—stomach cancer	3.45e-05	0.000149	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—stomach cancer	3.44e-05	0.000148	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCND1—stomach cancer	3.42e-05	0.000148	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6R—stomach cancer	3.42e-05	0.000147	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—JUN—stomach cancer	3.42e-05	0.000147	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	3.35e-05	0.000145	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	3.35e-05	0.000145	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—stomach cancer	3.33e-05	0.000143	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	3.31e-05	0.000143	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	3.28e-05	0.000141	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	3.23e-05	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	3.22e-05	0.000139	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	3.2e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	3.2e-05	0.000138	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	3.17e-05	0.000137	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RHOA—stomach cancer	3.09e-05	0.000133	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD44—stomach cancer	3.06e-05	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—stomach cancer	3.06e-05	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	3.05e-05	0.000132	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	3.03e-05	0.000131	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	2.99e-05	0.000129	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	2.98e-05	0.000128	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—stomach cancer	2.96e-05	0.000127	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	2.91e-05	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—stomach cancer	2.9e-05	0.000125	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	2.86e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCND1—stomach cancer	2.84e-05	0.000123	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JUN—stomach cancer	2.84e-05	0.000122	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	2.82e-05	0.000122	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—stomach cancer	2.76e-05	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	2.75e-05	0.000119	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—stomach cancer	2.75e-05	0.000118	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	2.71e-05	0.000117	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	2.69e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	2.69e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—stomach cancer	2.69e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	2.68e-05	0.000116	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	2.65e-05	0.000114	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.6e-05	0.000112	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.58e-05	0.000111	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTP1—stomach cancer	2.55e-05	0.00011	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KRAS—stomach cancer	2.54e-05	0.000109	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.52e-05	0.000109	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.52e-05	0.000109	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—stomach cancer	2.52e-05	0.000109	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.48e-05	0.000107	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.45e-05	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.45e-05	0.000106	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.44e-05	0.000105	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.38e-05	0.000103	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—TYMS—stomach cancer	2.37e-05	0.000102	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTM1—stomach cancer	2.35e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.34e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.33e-05	0.000101	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.28e-05	9.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.26e-05	9.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.23e-05	9.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.23e-05	9.62e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ERCC2—stomach cancer	2.21e-05	9.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.2e-05	9.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.18e-05	9.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.16e-05	9.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KRAS—stomach cancer	2.11e-05	9.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	2.08e-05	8.98e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—stomach cancer	2.07e-05	8.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—stomach cancer	2.07e-05	8.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—stomach cancer	2.03e-05	8.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	1.98e-05	8.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—stomach cancer	1.98e-05	8.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1.94e-05	8.35e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—stomach cancer	1.91e-05	8.25e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—stomach cancer	1.91e-05	8.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—stomach cancer	1.87e-05	8.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KRAS—stomach cancer	1.87e-05	8.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.79e-05	7.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.72e-05	7.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.71e-05	7.39e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—stomach cancer	1.68e-05	7.25e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.66e-05	7.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.59e-05	6.86e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.52e-05	6.56e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—stomach cancer	1.51e-05	6.52e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—stomach cancer	1.45e-05	6.24e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—stomach cancer	1.32e-05	5.7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.14e-06	3.51e-05	CbGpPWpGaD
